Photo from Guilherme Nader Marta/X
Jul 14, 2023, 18:15
Meta-analysis on the prognostic value of HER2-low in breast cancer – Guilherme Nader Marta
Now out in ESMO Open our meta-analysis led by chiara molinelli on the prognostic value of HER2-low in breast cancer including data from ~1.8 million patients!
HER2-low showed slightly better outcomes and the interaction with ER/PR appears to be relevant.
For article: Click here
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14